Buschulte, Katharina
Kabitz, Hans-Joachim
Hagmeyer, Lars
Hammerl, Peter
Esselmann, Albert
Wiederhold, Conrad
Skowasch, Dirk
Stolpe, Christoph
Joest, Marcus
Veitshans, Stefan
Höffgen, Marc
Maqhuzu, Phillen
Schwarzkopf, Larissa
Hellmann, Andreas
Pfeifer, Michael
Behr, Jürgen
Karpavicius, Rainer
Günther, Andreas
Polke, Markus
Höger, Philipp
Somogyi, Vivien
Lederer, Christoph
Markart, Philipp
Kreuter, Michael
Article History
Received: 16 August 2023
Accepted: 30 October 2023
First Online: 4 January 2024
Declarations
:
: The study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and was approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg, Germany (S-525/2013) as well as by all local ethics committees of the participating centres. Informed consent to participate in the study was obtained from all participants.
: Not applicable.
: KB received payment for lectures from Boehringer Ingelheim and a grant from Sarkoidose-Netzwerk e.V. DS reports fees for lectures or consultations from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Janssen, MSD, Sanofi, all outside the submitted work. CS reports fees for lectures GSK, AstraZeneca, Boehringer Ingelheim, Berlin Chemie. MJ reports fees for lectures or consultations from AstraZeneca, Bencard, Boehringer Ingelheim, GSK, HAL Allergy, Sanofi, all outside the submitted work. SV reports fees from Berlin Chemie, GSK, Lilly and Boehringer-Ingelheim. JB reports personal fees for lectures and consulting from Astra-Zeneca, Biogen, Boehringer-Ingelheim, BMS, Ferrer, Novartis, Roche, and Sanofi-Genzyme. MP has received payment or honoraria for lectures, presentations or educational events from Boehringer Ingelheim and AstraZeneca. VS received support for attending meetings from CSL Behring. PM received fees for consulting and lectures from Boehringer-Ingelheim and Roche. MK reports grants, consulting fees, and payment for lectures from Boehringer Ingelheim and Roche. All other authors have nothing to disclose.